ATTICUS PHARMA INC: Phase 2: Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus
ATTICUS PHARMA INC (Greenville, South Carolina): Phase 2: Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus. Its award of $1,007,121 is above the median of $407,048 (87th percentile). Dated 46 days ago, it serves as a historical benchmark. Score 70/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
award: $1,007,121 · 87th percentile of 10,712 NihBiotechGrantPulse records · 2.5x the median
Free preview: all 10 published fields of this record are shown below. Locked: 115 related SC NihBiotechGrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Organization | ATTICUS PHARMA INC |
| Location | GREENVILLE, SC |
| Project | Phase 2: Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus |
| Project number | 1R44AR087266-01A1 |
| Mechanism | R44 |
| Institute | National Institute of Arthritis and Musculoskeletal and Skin Diseases |
| Award | $1,007,121 |
| Awarded | 2026-09-19 |
| Project period | 2026-09-25 to 2028-08-31 |
| UEI | LZXUMNXR3AB5 |
| award percentile | 87th of 10,712 (median $407,048, 2.5x median) |
| Peer records CSV (116 SC records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch ATTICUS PHARMA INC
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock ATTICUS PHARMA + all 116 SC records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL
- Source agency: NIH RePORTER (newly awarded projects)
- Record date: 2026-09-19
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top NihBiotechGrantPulse records (SC first): UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · Browse all by state and category →
LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: ATTICUS PHARMA INC and 116 South Carolina peers
- South Carolina NihBiotechGrantPulse records like this one: 116
- ATTICUS PHARMA INC's award: 87th percentile of 10,712 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every South Carolina peer: $23,200 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
70 / 100 Lab Budget Score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.
What is the NihBiotechGrantPulse record for ATTICUS PHARMA INC in Greenville, South Carolina?
ATTICUS PHARMA INC received an NIH award of $1,007,121 on 2026-09-19: Phase 2: Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.
How does ATTICUS PHARMA INC compare to other South Carolina NihBiotechGrantPulse records?
Its award of $1,007,121 sits in the upper half (87th percentile) of 10,712 records; the median is $407,048. It is 46 days old; check the official source for later updates before acting. Its Lab Budget Score of 70/100 puts it among the stronger signals in this feed.
ATTICUS PHARMA INC vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date | Compare |
|---|---|---|---|---|---|
| ATTICUS PHARMA INC | GREENVILLE, SC | 1,007,121 | 87th | 2026-09-19 | This record |
| MEDICAL UNIVERSITY OF SOUTH CAROLINA | CHARLESTON, SC | 1,125,622 | 89th | 2026-09-10 | Compare ATTICUS PHARMA INC vs MEDICAL UNIVERSITY OF SOUTH CAROLINA → |
| UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA | COLUMBIA, SC | 1,272,876 | 91st | 2026-09-08 | View record → |
| PRISMA HEALTH - UPSTATE | GREENVILLE, SC | 1,329,328 | 91st | 2026-09-07 | View record → |
Related records
- MEDICAL UNIVERSITY OF SOUTH CAROLINA
- UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
- UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
- MEDICAL UNIVERSITY OF SOUTH CAROLINA
- MEDICAL UNIVERSITY OF SOUTH CAROLINA
- UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
- SPARTANBURG REGIONAL MEDICAL CENTER
- PRISMA HEALTH - UPSTATE
- CLEMSON UNIVERSITY
- MEDICAL UNIVERSITY OF SOUTH CAROLINA
- MEDICAL UNIVERSITY OF SOUTH CAROLINA
- MEDICAL UNIVERSITY OF SOUTH CAROLINA
NihBiotechGrantPulse: records in South Carolina NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)
More South Carolina public-record feeds
FMCSA Trucking Insurance Cancellations by Carrier, Insurer & Fleet Size in South Carolina New MSHA Citations at Mines & Quarries by State in South Carolina Newly Posted IRS Automatic Revocations of Tax Exemption in South Carolina Excluded Health Care Business Search (OIG LEIE) in South Carolina New & Re-Approved E-Rate Service Providers (FCC Form 498 / SPIN) in South Carolina New, Terminating & Large 401(k) Plans from Form 5500 Filings in South Carolina Federal Alcohol Permit Holder Directory in South Carolina Nursing Home Inspection Deficiencies by State & Severity in South Carolina
How to monitor ATTICUS PHARMA INC and peer small business sbir/sttr (r41-r44, u43-u44) records
Get new NihBiotechGrantPulse records like ATTICUS PHARMA INC by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.